What is Radient Technologies?
Radient Technologies operates as a commercial manufacturer specializing in high-quality cannabinoid-based formulations, ingredients, and products. The company is strategically positioned within the burgeoning cannabis industry, focusing on the development and production of derived goods. Its operations are centered in Edmonton, Alberta, Canada, a region with a developing framework for cannabis commercialization.
How much funding has Radient Technologies raised?
Radient Technologies has raised a total of $13.9M across 3 funding rounds:
Debt
$8.5M
Stock Offering
$5M
Share Placement
$360K
Debt (2019): $8.5M with participation from Moskowitz Capital
Stock Issuance/Offering (2020): $5M led by Undisclosed
Share Placement (2022): $360K, investors not publicly disclosed
Key Investors in Radient Technologies
Moskowitz Capital
Moskowitz Capital is an entity that has provided debt financing to Radient Technologies, indicating a role in the company's capital structure.
Undisclosed Investors
What's next for Radient Technologies?
With the recent major strategic investment, Radient Technologies is poised for accelerated expansion and product development. The enterprise-level capital infusion suggests a focus on scaling production capabilities, enhancing research and development for novel cannabinoid applications, and potentially broadening market reach. This strategic backing is expected to fortify the company's competitive position in the global cannabinoid market, enabling further innovation and operational efficiencies.
See full Radient Technologies company page
